Skip to content
10-Q

Quarterly Report

PARATEK PHARMACEUTICALS, INC.

0001628280-23-027035

← back to feed
Filed
Aug 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 31, 2023 57.32M sh
Shares Diluted Q2 2023 · Jun 30, 2023 57.28M sh
Shares Diluted Q2 2023 · Jun 30, 2023 57.09M sh
Shares Diluted Q2 2023 · Jun 30, 2022 53.02M sh
Shares Diluted Q2 2023 · Jun 30, 2022 53.31M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 $9.31M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$33.61M
Long Term Debt Q2 2023 · Jun 30, 2023 $94.29M
Long Term Debt Q2 2023 · Dec 31, 2022 $256.95M
Short Term Debt Q2 2023 · Jun 30, 2023 $164.04M
Short Term Debt Q2 2023 · Dec 31, 2022 $0
Cash And Equivalents Q2 2023 · Jun 30, 2023 $42.69M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $34.25M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $39.51M
Stockholders Equity Q2 2023 · Jun 30, 2023 −$201.37M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$189.04M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$171.04M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$149.37M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$140.3M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$127.79M
Current Liabilities Q2 2023 · Jun 30, 2023 $202.62M
Current Liabilities Q2 2023 · Dec 31, 2022 $37.39M
Total Liabilities Q2 2023 · Jun 30, 2023 $347.16M
Total Liabilities Q2 2023 · Dec 31, 2022 $343.58M
Current Assets Q2 2023 · Jun 30, 2023 $105.23M
Current Assets Q2 2023 · Dec 31, 2022 $136.84M
Total Assets Q2 2023 · Jun 30, 2023 $145.79M
Total Assets Q2 2023 · Dec 31, 2022 $172.54M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.25
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.61
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.33
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.67
Eps Basic Q2 2023 · Jun 30, 2023 −$0.25
Eps Basic Q2 2023 · Jun 30, 2023 −$0.61
Eps Basic Q2 2023 · Jun 30, 2022 −$0.33
Eps Basic Q2 2023 · Jun 30, 2022 −$0.67
Sga Expense Q2 2023 · Jun 30, 2023 $36.26M
Sga Expense Q2 2023 · Jun 30, 2023 $69.75M
Sga Expense Q2 2023 · Jun 30, 2022 $30.34M
Sga Expense Q2 2023 · Jun 30, 2022 $57.94M
Net Income Q2 2023 · Jun 30, 2023 −$14.55M
Net Income Q2 2023 · Jun 30, 2023 −$34.7M
Net Income Q2 2023 · Mar 31, 2023 −$20.14M
Net Income Q2 2023 · Jun 30, 2022 −$17.62M
Net Income Q2 2023 · Jun 30, 2022 −$35.53M
Net Income Q2 2023 · Mar 31, 2022 −$17.91M
Operating Income Q2 2023 · Jun 30, 2023 −$9.41M
Operating Income Q2 2023 · Jun 30, 2023 −$25.22M
Operating Income Q2 2023 · Jun 30, 2022 −$13.17M
Operating Income Q2 2023 · Jun 30, 2022 −$26.88M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $4.37M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $10.61M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $4.88M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $8.37M
Revenue Q2 2023 · Jun 30, 2023 $39.99M
Revenue Q2 2023 · Jun 30, 2023 $71.23M
Revenue Q2 2023 · Jun 30, 2022 $29.64M
Revenue Q2 2023 · Jun 30, 2022 $54.5M